View of Abemaciclib in real clinical practice of adjuvant therapy of HR+/HER2- high-risk breast cancer: experience of centers in Moscow | Voprosy onkologii

← Abemaciclib in real clinical practice of adjuvant therapy of HR+/HER2- high-risk breast cancer: experience of centers in Moscow